Stock listing
KRX:217330 CytoGen, Inc. (싸이토젠) 주가
Follow CytoGen, Inc. into a list and get an email when it puts out news.
Share price · KRX:217330
₩2,245.00 KRW -45.00 (-2.0%)
Close on Nov 20, 2026
- Day range
- ₩2,155.00 – ₩2,340.00 KRWNov 20, 2026
- Volume
- 26,887 sharesNov 20, 2026
- Market cap
- ₩51.92B KRWAt the close on Nov 20, 2026 · price × 23.13M shares outstanding
- 52-week range
- ₩2,100.00 – ₩11,200.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩150.9M KRWMedian day 49,934 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:217330 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩2,245.00 | -45.00 | -2.0% | ₩2,285.00 | ₩2,340.00 | ₩2,155.00 | 26,887 | |
| ₩2,290.00 | -5.00 | -0.2% | ₩2,295.00 | ₩2,360.00 | ₩2,235.00 | 18,430 | |
| ₩2,295.00 | +40.00 | +1.8% | ₩2,255.00 | ₩2,320.00 | ₩2,220.00 | 40,541 | |
| ₩2,255.00 | -65.00 | -2.8% | ₩2,385.00 | ₩2,400.00 | ₩2,220.00 | 54,537 | |
| ₩2,320.00 | 0.00 | 0.0% | ₩2,370.00 | ₩2,390.00 | ₩2,290.00 | 28,848 | |
| ₩2,320.00 | -10.00 | -0.4% | ₩2,400.00 | ₩2,400.00 | ₩2,295.00 | 22,414 | |
| ₩2,330.00 | +100.00 | +4.5% | ₩2,230.00 | ₩2,350.00 | ₩2,225.00 | 39,848 | |
| ₩2,230.00 | +45.00 | +2.1% | ₩2,185.00 | ₩2,275.00 | ₩2,185.00 | 20,966 | |
| ₩2,185.00 | -20.00 | -0.9% | ₩2,170.00 | ₩2,250.00 | ₩2,140.00 | 38,464 | |
| ₩2,205.00 | 0.00 | 0.0% | ₩2,200.00 | ₩2,255.00 | ₩2,100.00 | 38,696 | |
| ₩2,205.00 | -25.00 | -1.1% | ₩2,255.00 | ₩2,390.00 | ₩2,205.00 | 28,553 | |
| ₩2,230.00 | +5.00 | +0.2% | ₩2,250.00 | ₩2,300.00 | ₩2,180.00 | 50,314 | |
| ₩2,225.00 | -95.00 | -4.1% | ₩2,300.00 | ₩2,315.00 | ₩2,220.00 | 36,280 | |
| ₩2,320.00 | +5.00 | +0.2% | ₩2,400.00 | ₩2,400.00 | ₩2,300.00 | 24,975 | |
| ₩2,315.00 | -30.00 | -1.3% | ₩2,345.00 | ₩2,415.00 | ₩2,290.00 | 53,029 | |
| ₩2,345.00 | -130.00 | -5.3% | ₩2,430.00 | ₩2,455.00 | ₩2,340.00 | 69,322 | |
| ₩2,475.00 | +25.00 | +1.0% | ₩2,450.00 | ₩2,620.00 | ₩2,425.00 | 54,613 | |
| ₩2,450.00 | -50.00 | -2.0% | ₩2,550.00 | ₩2,630.00 | ₩2,435.00 | 47,414 | |
| ₩2,500.00 | -5.00 | -0.2% | ₩2,510.00 | ₩2,625.00 | ₩2,460.00 | 38,105 | |
| ₩2,505.00 | -140.00 | -5.3% | ₩2,645.00 | ₩2,645.00 | ₩2,485.00 | 73,213 | |
| ₩2,645.00 | -25.00 | -0.9% | ₩2,755.00 | ₩2,850.00 | ₩2,625.00 | 68,053 | |
| ₩2,670.00 | +5.00 | +0.2% | ₩2,705.00 | ₩2,800.00 | ₩2,560.00 | 53,990 | |
| ₩2,665.00 | -35.00 | -1.3% | ₩2,780.00 | ₩2,845.00 | ₩2,600.00 | 38,367 | |
| ₩2,700.00 | +5.00 | +0.2% | ₩2,700.00 | ₩2,730.00 | ₩2,645.00 | 25,140 | |
| ₩2,695.00 | +75.00 | +2.9% | ₩2,620.00 | ₩2,745.00 | ₩2,605.00 | 27,049 | |
| ₩2,620.00 | -105.00 | -3.9% | ₩2,810.00 | ₩2,875.00 | ₩2,590.00 | 71,959 | |
| ₩2,725.00 | -30.00 | -1.1% | ₩2,755.00 | ₩2,840.00 | ₩2,710.00 | 49,553 | |
| ₩2,755.00 | -15.00 | -0.5% | ₩2,770.00 | ₩2,770.00 | ₩2,645.00 | 92,143 | |
| ₩2,770.00 | -155.00 | -5.3% | ₩2,955.00 | ₩2,995.00 | ₩2,760.00 | 77,157 | |
| ₩2,925.00 | -145.00 | -4.7% | ₩3,045.00 | ₩3,070.00 | ₩2,925.00 | 107,396 | |
| ₩3,070.00 | -45.00 | -1.4% | ₩3,150.00 | ₩3,195.00 | ₩3,060.00 | 42,336 | |
| ₩3,115.00 | -95.00 | -3.0% | ₩3,210.00 | ₩3,300.00 | ₩3,115.00 | 116,654 | |
| ₩3,210.00 | -15.00 | -0.5% | ₩3,280.00 | ₩3,410.00 | ₩3,210.00 | 99,848 | |
| ₩3,225.00 | +185.00 | +6.1% | ₩3,075.00 | ₩3,245.00 | ₩3,060.00 | 88,186 | |
| ₩3,040.00 | +10.00 | +0.3% | ₩3,030.00 | ₩3,140.00 | ₩3,020.00 | 27,898 | |
| ₩3,030.00 | -155.00 | -4.9% | ₩3,185.00 | ₩3,185.00 | ₩3,015.00 | 48,291 | |
| ₩3,185.00 | +160.00 | +5.3% | ₩3,025.00 | ₩3,230.00 | ₩3,010.00 | 90,426 | |
| ₩3,025.00 | +20.00 | +0.7% | ₩3,000.00 | ₩3,075.00 | ₩2,960.00 | 28,910 | |
| ₩3,005.00 | -60.00 | -2.0% | ₩3,070.00 | ₩3,090.00 | ₩3,000.00 | 38,021 | |
| ₩3,065.00 | -5.00 | -0.2% | ₩3,060.00 | ₩3,090.00 | ₩3,035.00 | 53,562 | |
| ₩3,070.00 | +10.00 | +0.3% | ₩3,080.00 | ₩3,100.00 | ₩3,005.00 | 40,415 | |
| ₩3,060.00 | +90.00 | +3.0% | ₩3,000.00 | ₩3,140.00 | ₩2,985.00 | 52,858 | |
| ₩2,970.00 | -50.00 | -1.7% | ₩3,100.00 | ₩3,100.00 | ₩2,945.00 | 70,084 | |
| ₩3,020.00 | +25.00 | +0.8% | ₩2,945.00 | ₩3,040.00 | ₩2,945.00 | 50,754 | |
| ₩2,995.00 | -60.00 | -2.0% | ₩3,055.00 | ₩3,055.00 | ₩2,940.00 | 50,890 | |
| ₩3,055.00 | -35.00 | -1.1% | ₩3,090.00 | ₩3,090.00 | ₩3,005.00 | 62,146 | |
| ₩3,090.00 | +40.00 | +1.3% | ₩3,050.00 | ₩3,095.00 | ₩3,010.00 | 47,200 | |
| ₩3,050.00 | -15.00 | -0.5% | ₩3,065.00 | ₩3,100.00 | ₩3,015.00 | 45,336 | |
| ₩3,065.00 | +10.00 | +0.3% | ₩3,055.00 | ₩3,105.00 | ₩3,040.00 | 45,834 | |
| ₩3,055.00 | +40.00 | +1.3% | ₩3,100.00 | ₩3,100.00 | ₩2,995.00 | 70,791 | |
| ₩3,015.00 | 0.00 | 0.0% | ₩3,005.00 | ₩3,045.00 | ₩2,965.00 | 55,184 | |
| ₩3,015.00 | -25.00 | -0.8% | ₩3,020.00 | ₩3,130.00 | ₩2,995.00 | 49,356 | |
| ₩3,040.00 | -105.00 | -3.3% | ₩3,145.00 | ₩3,145.00 | ₩3,035.00 | 47,667 | |
| ₩3,145.00 | 0.00 | 0.0% | ₩3,145.00 | ₩3,160.00 | ₩3,055.00 | 50,427 | |
| ₩3,145.00 | -40.00 | -1.3% | ₩3,180.00 | ₩3,180.00 | ₩3,040.00 | 56,237 | |
| ₩3,185.00 | -15.00 | -0.5% | ₩3,200.00 | ₩3,225.00 | ₩3,120.00 | 29,665 | |
| ₩3,200.00 | -100.00 | -3.0% | ₩3,300.00 | ₩3,370.00 | ₩3,170.00 | 68,993 | |
| ₩3,300.00 | -60.00 | -1.8% | ₩3,355.00 | ₩3,520.00 | ₩3,125.00 | 79,629 | |
| ₩3,360.00 | +140.00 | +4.3% | ₩3,220.00 | ₩3,360.00 | ₩3,075.00 | 60,842 | |
| ₩3,220.00 | +65.00 | +2.1% | ₩3,155.00 | ₩3,245.00 | ₩3,140.00 | 39,173 | |
| ₩3,155.00 | -240.00 | -7.1% | ₩3,390.00 | ₩3,390.00 | ₩3,150.00 | 65,621 | |
| ₩3,395.00 | +20.00 | +0.6% | ₩3,385.00 | ₩3,580.00 | ₩3,290.00 | 82,527 |
Splits
1 split · KRX:217330 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 3-for-1 | Split |
- Ticker
- KRX:217330
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- KRX
- Currency
- KRW
Latest news
CytoGen, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 1 in all · newest Nov 5, 2025 · oldest 2025
- Decks
- 7 decks · latest Sep 14, 2005
Valuation
EV/sales 1.6× against a median of 0.8×: 7th lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩42.61B KRW
- P/E
- Loss
- EV/sales
- 1.6×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.6×
- Gross margin
- 24.4%
- Operating margin
- −21.4%
- Net margin
- −38.5%
- Debt to equity
- 0.4×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| CytoGen, Inc. · KRX:217330 | US$38.58M | US$31.66M | n/a | 1.6× | n/a | 1.6× | −38.5% | 0.4× | n/a |
| EDX Medical Group plc · LSE:EDX | US$43.78M | US$39.96M | n/a | 92.3× | n/a | 15.4× | n/a | 0.0× | n/a |
| Osang Healthcare Co. Ltd. · KRX:036220 | US$42.35M | US$24.18M | n/a | 0.3× | n/a | 0.2× | −8.8% | 0.1× | n/a |
| ABL Diagnostics SA · EURONEXT:ABLD | US$41.27M | US$42.32M | 38.1× | 5.5× | 42.8× | 5.3× | 14.2% | 0.3× | n/a |
| hVIVO plc · LSE:HVO | US$41.02M | US$42.24M | n/a | 0.7× | 7.5× | 1.0× | −12.8% | 0.4× | n/a |
| Harvard Bioscience, Inc. · NASDAQ:HBIO | US$39.60M | US$71.90M | n/a | 0.8× | 28.4× | 7.8× | −13.2% | 7.3× | 1.34 |
| HUMASIS Co., Ltd. · KRX:205470 | US$37.48M | −US$89.14M | n/a | −3.8× | n/a | 0.2× | −49.2% | 0.0× | n/a |
| IXICO PLC · LSE:IXI | US$37.28M | US$35.82M | n/a | 4.2× | n/a | 2.7× | −25.3% | 0.1× | n/a |
| Mabion SA · GPW:MAB | US$35.42M | US$41.98M | n/a | 9.7× | n/a | 6.0× | −321.4% | 1.3× | n/a |
| Trajan Group Holdings Ltd · ASX:TRJ | US$34.93M | US$64.96M | n/a | 0.6× | 7.6× | 0.5× | −0.4% | 0.6× | n/a |
| Novacyt SAS · EURONEXT:ALNOV | US$33.87M | US$35.59M | n/a | 0.8× | n/a | 1.4× | −102.4% | 0.6× | n/a |
| Median of the others | US$38.54M | US$40.97M | 38.1× | 0.8× | 18.0× | 2.0× | −13.2% | 0.3× | 1.34 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Feb 21, 2024 · Before open | −3.8% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2005) | Investor deck | 15 slides | Sep 14, 2005 |
| Investor Presentation (September 2005) | Investor deck | 18 slides | Sep 14, 2005 |
| Technical Presentation (September 2005) | Technical | 29 slides | Sep 14, 2005 |
| Technical Presentation (September 2005) | Technical | 32 slides | Sep 14, 2005 |
| Technical Presentation (September 2005) | Technical | 40 slides | Sep 14, 2005 |
| Technical Presentation (September 2005) | Technical | 25 slides | Sep 14, 2005 |
| Technical Presentation (September 2005) | Technical | 15 slides | Sep 14, 2005 |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26.1B | 10.9B | 3.18B | 760.8M | 347.8M | 642.7M | 798.9M | 1.23B | 205.9M | 849.8M |
| Cost of revenue | 20.4B | 8.08B | 2.34B | 565.6M | 290.6M | 772.3M | 985.6M | 913.3M | 179.5M | 586.9M |
| Gross profit | 5.61B | 2.83B | 846.2M | 195.2M | 57.3M | -129.6M | -186.7M | 312.2M | 26.4M | 262.9M |
| Research and development | 1.89B | 2.84B | 3.12B | 3.20B | 3.32B | 1.74B | 1.23B | 180.7M | 98.1M | 512.7M |
| Selling, general and administrative | 3.81B | 9.25B | 8.34B | 7.70B | 8.62B | 3.72B | 2.27B | 2.41B | 2.01B | 2.04B |
| Operating income | -7.48B | -14.0B | -14.0B | -11.3B | -12.9B | -6.59B | -4.49B | -2.63B | -2.28B | -2.61B |
| Depreciation and amortization | 3.17B | 1.66B | 1.62B | 1.22B | 1.01B | 1.04B | 976.7M | 432.4M | 263.9M | 289.1M |
| EBITDA | -4.31B | -12.4B | -12.4B | -10.1B | -11.9B | -5.54B | -3.51B | -2.20B | -2.01B | -2.32B |
| Interest expense | 2.33B | 2.09B | 3.04B | 3.93B | 2.66B | 222.0M | 0 | 0 | 0 | 0 |
| Income before tax | -13.0B | -17.9B | -16.2B | -18.7B | -13.3B | -5.01B | -4.14B | -2.60B | -2.62B | -2.15B |
| Income tax | -121.1M | 0 | 0 | 0 | ||||||
| Net income | -12.3B | -17.1B | -15.8B | -18.8B | -10.9B | -4.89B | -4.14B | -2.60B | -2.62B | -2.15B |
| Earnings per share, basic | -533.70 | -741.97 | -711.80 | -1,054.05 | -621.09 | -867.75 | -734.98 | -461.35 | -595.78 | -557.37 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 11.0B | 31.2B | 54.8B | 595.7K | 30.3B | 11.1B | 10.1B | 2.09B | 4.40B | 2.80B |
| Short-term investments | 20.5B | 10.0B | 49.5M | 223.2M | 5.09B | 4.82B | 2.76B | 10.6B | 110.0M | |
| Receivables | 6.08B | 3.95B | 474.0M | 588.2M | 88.9M | 936.7M | 1.34B | 457.5M | 99.9M | 575.3M |
| Inventory | 4.39B | 1.72B | 25.3M | 131.5M | 62.6M | 62.6M | ||||
| Current assets | 43.2B | 48.1B | 56.0B | 19.4B | 43.6B | 22.4B | 14.3B | 20.2B | 4.72B | 3.62B |
| Property, plant and equipment | 6.83B | 4.98B | 3.10B | 2.81B | 1.73B | 2.37B | 1.63B | 728.8M | 906.1M | |
| Goodwill | 4.83B | 4.83B | 2.72B | 5.71B | ||||||
| Total assets | 62.2B | 72.5B | 74.5B | 41.2B | 55.5B | 28.3B | 19.7B | 22.8B | 5.68B | 5.06B |
| Accounts payable | 3.46B | 1.67B | 206.6M | 189.2M | 112.6M | 67.1M | 141.5M | 69.2M | 51.3M | |
| Current liabilities | 14.7B | 4.71B | 10.7B | 33.9B | 6.79B | 1.17B | 1.07B | 488.2M | 762.9M | 2.10B |
| Long-term debt | 10.7B | 13.3B | 8.37B | 20.4B | 5.38B | 1.93B | ||||
| Total debt | 5.51B | 458.9M | 2.31B | |||||||
| Total liabilities | 26.2B | 23.9B | 21.1B | 35.6B | 32.5B | 9.97B | 1.80B | 711.5M | 947.5M | 4.59B |
| Shareholders' equity | 35.6B | 48.6B | 53.4B | 5.66B | 23.0B | 18.3B | 17.9B | 22.0B | 4.73B | 475.5M |
| Shares outstanding | 23.1M | 23.1M | 22.2M | 17.8M | 17.5M | 5.63M | 5.63M | 5.63M | 4.40M | 3.86M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -6.95B | -9.53B | -7.59B | -6.38B | -5.23B | -4.47B | -3.37B | -2.77B | -2.18B | -2.36B |
| Capital spending | -2.04B | -1.12B | -2.62B | -745.0M | -2.00B | -269.7M | -559.8M | -1.31B | -314.8M | -347.3M |
| Free cash flow | -8.99B | -10.7B | -10.2B | -7.12B | -7.23B | -4.92B | -3.93B | -4.08B | -2.49B | -2.71B |
| Cash from investing | -24.3B | 263.4M | -6.65B | -5.58B | -4.09B | 11.7B | -19.1B | 305.8M | -232.4M | |
| Cash from financing | 9.17B | 46.2B | -1.04B | 30.0B | 9.64B | -343.1M | 19.6B | 3.48B | 2.98B | |
| Share buybacks | 6.50B | 40.0B | 1.12B | 409.9M | 20.0B | 3.49B | ||||
| Change in cash | -20.2B | -24.7B | 39.0B | -14.4B | 19.2B | 1.01B | 7.97B | -2.31B | 1.60B | 384.9M |
Cap table
Built by 6ix from CytoGen, Inc.’s releases
- Common shares
- 23,126,859
- Fully diluted
- 23,126,859
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 23,126,859 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 23,126,859 |
Log in to ask 6ix AI your own questions about CytoGen, Inc.